Clinical Trial Update: A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating oral dosing of ASP0456 in patients with chronic constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• ASP0456

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Constipation | Phase 3 | Status: COMPLETED